Go to Top

In the Spotlight

Randall Starling, Ph.D.

Randall Starling, Ph.D. Senior Scientist 2 Center on Alcoholism, Substance Abuse, and Addictions (CASAA) The University of New Mexico Dr. Starling’s current research areas focus on alcohol and drug research; Prevention of Fetal Alcohol Spectrum Disorders (FASD); Prevention of drinking and drugs in adolescents; Research on HPV vaccine uptake; Mobile technology to deliver tailored information and feedback to users; and Identifying and correcting risky drinking behavior. REGISTERED U.S. TRADEMARK (UNM-AFFILIATED) 85/197,189, WAYTOSERVE®, …Read More

Aaron K. Neumann, Ph.D.

Aaron K. Neumann, Ph.D. Associate Professor Department of Pathology Health Sciences The University of New Mexico Dr. Neumann’s current research focuses on Cell biology and signal transduction of fungal pathogen sensing via C-type lectins in dendritic cells and macrophages; Nanostructure in the fungal call walls and innate immunoreceptors with respect to its impact on the success or failure of anti-fungal immunity; Quantitative live-cell optical microscopy techniques to investigate host-microbe interactions …Read More

Hongyou Fan, Ph.D.

Hongyou Fan, Ph.D. National Laboratory Professor, Department of Chemical & Biological Engineering Center for Micro-Engineered Materials The University of New Mexico Dr. Fan’s current research focuses on the development of new synthesis methods and self-assembly processes to fabricate multifunctional nanomaterials; fundamentally understanding self-assembly mechanisms and structural evolution from the molecular to the nano- and micro-scale scale; and understanding structure-property relationships. ISSUED U. S. PATENTS (UNM-AFFILIATED) 6,471,761 Prototyping of Patterned Functional …Read More

Mark Hauswald, M.D.

Mark Hauswald, M.D. Professor Emeritus, Department of Emergency Medicine Director, Global Health Program Associate Dean Emeritus Health Sciences The University of New Mexico Telluride Medical Solutions, Inc. (STC startup) Dr. Hauswald has disclosed five inventions, received four UNM-affiliated issued U. S. patents, has one pending patent application, and has a license agreement with startup Telluride Medical Solutions, Inc. for his patient-controlled analgesia device. Many medications need to be titrated to effect. For …Read More

Edl Schamiloglu, Ph.D.

Edl Schamiloglu, Ph.D. Distinguished Professor, Department of Electrical & Computer Engineering Associate Dean for Research, School of Engineering The University of New Mexico Dr. Schamiloglu has disclosed six inventions, received four UNM-affiliated issued U.S. patents, and has one pending patent application for his magnetron technologies. Magnetrons are devices that generate microwaves using crossed electric and magnetic fields to produce high-power output required, for instance, in radar equipment.  Cathode performance plays …Read More

Richard C. Harvey, Ph.D.

Richard C. Harvey, Ph.D. Research Professor, Department of Pathology Health Sciences The University of New Mexico Dr. Harvey has disclosed three inventions, received one UNM-affiliated issued U. S. patent, and has one pending patent application for his leukemia technologies. Acute lymphoblastic leukemia is the most common type of cancer in children. High-risk B-precursor acute lymphoblastic leukemia (B-ALL) patients are fewer in number and have not been well studied. In the …Read More

Christina Salas, Ph.D.

Christina Salas, Ph.D. Assistant Professor, Departments of Orthopaedics & Rehabilitation and Mechanical Engineering The University of New Mexico Dr. Salas has disclosed ten inventions, received one UNM-affiliated issued U. S. patent, and has five pending patent applications for her tissue engineering technologies for orthopaedic applications. Current surgical treatment of fractures in subcutaneous bones can be technically challenging and can lead to problems related to prominent metal surgical implants.  Current methods …Read More

Alexandre Chigaev, Ph.D.

Alexandre Chigaev, Ph.D. Research Associate Professor, Department of Pathology, Center for Molecular Discovery Health Sciences The University of New Mexico Dr.  Chigaev has disclosed five inventions, received two UNM-affiliated issued U. S. patents, and has one pending patent application for his drug discovery technologies. Integrins are a family of extracellular adhesion receptors that can be therapeutic targets for multiple human diseases. They mediate cell-to-cell or cell-to-extracellular matrix adhesion and play …Read More

Susan R. Atlas, Ph.D.

Susan R. Atlas, Ph.D. Research Professor, Department of Physics & Astronomy The University of New Mexico Dr. Atlas has disclosed five inventions and received one UNM-affiliated issued U. S. patent for her leukemia-related technologies. Acute lymphoblastic leukemia is the most common type of cancer in children. High-risk B-precursor acute lymphoblastic leukemia (B-ALL) patients are fewer in number and have not been well studied. In the United States, over 62,130 new …Read More

Nora Perrone-Bizzozero, Ph.D.

Nora Perrone-Bizzozero, Ph.D. Professor, Department of Neurosciences Health Sciences The University of New Mexico Dr. Perrone-Bizzozero has disclosed two inventions and received one UNM-affiliated issued U. S. patent for her central nervous system (CNS) protein technology. Mental illness has a profound effect on public health, but psychiatry has had difficulty developing biological tests to diagnose, monitor and evaluate treatment for these and other brain disorders.  Researchers are interested in correlating …Read More